GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales

GoodRx Holdings Inc. GDRX reported fourth-quarter revenue of $198.6 million, up slightly by 1% year over year, missing the management guidance of around $200 million and consensus of $199.75 million.Fiscal year sales of $792.3 million came in below the guidance of around $794 million.The company reported adjusted EPS of 9 cents, up from 8 cents a year ago, missing the consensus of 10 cents.Q4 prescription transactions revenue increased 0.8% to $144.9 million. 2024 prescription transactions revenue increased ...